1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (RFA-EB-26-003) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB) / National Institutes of Health (NIH). This Notice of Funding Opportunity (NOFO) solicits applications to enhance bioengineering and imaging research capacity, technology innovation, education and research training, and opportunities for scientific growth at Historically Black Colleges and Universities (HBCUs).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities Agency: National Institutes of Health Assistance Listings: 93.
286 -- Discovery and Applied Research for Technological Innovations to Improve Human Health Last Updated: May 13, 2026 View version history on Grants.
gov The National Institute of Biomedical Imaging and Bioengineering intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to enhance bioengineering and imaging research capacity, technology innovation, education and research training, and opportunities for scientific growth at Historically Black College and Universities (HBCUs).
The planned NOFO aligns with the HBCU PARTNERS Act (Public Law 116-270) and Executive Order 14283, which seek to strengthen capacity and competitiveness of HBCUs; align HBCUs with educational and economic competitiveness priorities of the United States; encourage HBCU participation and competitiveness for Federal research and development funding through grants, contracts, and cooperative agreements; and foster public-private partnerships to promote centers of academic research and program excellence at HBCUs.
Applications are not being solicited at this time. This Notice is being provided to allow potential applicants time to develop meaningful collaborations and responsive projects. This NOFO will utilize the UG3/UH3 activity code.
HBCUs, defined as institutions listed in 34 C. F. R.
§ 608. 2 , will be eligible to apply. Investigators with expertise in bioengineering, biomedical imaging, and technology development are encouraged to consider applying for this NOFO.
Collaborative investigations combining expertise in bioengineering, imaging, and technology development with disease- or discipline-specific expertise in other areas of biomedical investigation will also be encouraged. Public and state institutions of higher education Private institutions of higher education Grantor contact information Please contact via e-mail. No documents are currently available.
Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: HBCUs, as defined in 34 C. F. R. § 608. 2. Investigators with expertise in bioengineering, biomedical imaging, and technology development are encouraged to apply. Confirm the full requirements in the official notice before applying.
The current listing shows $1,920,000 (Estimated Total Program Funding). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (RFA-EB-26-003) is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB) / National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
National Institute of Biomedical Imaging and Bioengineering (NIBIB) SBIR/STTR Program is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB) / National Institutes of Health (NIH). The NIBIB Small Business Program supports the development and integration of advanced biomedical imaging, bioengineering, sensing, and computational technologies. This includes novel medical device platforms, bio-electromagnetic technologies, health informatics (including digital health, mobile health, and telehealth), and diagnostic and therapeutic technologies.
NIBIB Biomedical Technology Resource Centers (P41) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB) / National Institutes of Health (NIH). This FOA encourages grant applications for Biomedical Technology Resource Centers (BTRCs) that conduct research and development on new technologies driven by the needs of basic, translational, and clinical researchers.
The NIBIB Trailblazer Award is an enhanced R21 mechanism for New and Early Stage Investigators (NIs/ESIs) to pursue research at the interface of life sciences with engineering and physical sciences — explicitly including artificial intelligence, machine learning, and deep learning for medical imaging and biomedical data analysis. Trailblazer projects receive up to $400,000 in direct costs over three years, and NIBIB encourages applications in computational imaging, AI-driven diagnostic algorithms, deep learning for medical image segmentation and classification, machine learning approaches to biomedical signal processing, and AI for digital pathology, radiology, and wearable health sensors. Beginning FY2026, NIH funding opportunities are posted exclusively on Grants.gov rather than the NIH Guide. Trailblazer complements NIBIB's standard R21 (capped at $275,000 over two years) and R01 pathway for larger established research programs.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe April 14 SBIR/STTR reauthorization restarted NIH's small-business pipeline after the shutdown, but the real signal is the sequencing of the new Small Business 101 webinars: program overview June 9, budget July 14, foreign risk August 18.
Read articleNIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read article